Spis treści:
Spis załącznikĂłw:
Sopharma_monthly_March_2016.doc (REPORT)
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załącznikĂłw:
Sopharma_monthly_March_2016.doc (REPORT)
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 35 | / | 2016 | ||||||||
| Date of issue: | 2016-04-05 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Sopharma monthly March 2016 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne |
|||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD notifies that for March 2016 the Company recorded a decrease of sales revenues of 19% compared to the same month of 2015, including 17% increase of domestic sales and 36% decrease of export sales. For the first three months of this year, revenues from sales increased by 2% compared to the same period of 2015, including 8% increase of domestic sales and a 1% decrease of export sales. |
|||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Sopharma monthly March 2016.docSopharma monthly March 2016.doc | Sopharma monthly March 2016 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2016-04-05 | Ognian Donev | Executive director | |||